Regorafenib Monohydrate/ 1019206-88-2
GMP ISO
1019206-88-2
99%
shanghai
1kg/10kg/100kg
2023-11-26
API,chemical
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceRegorafenib monohydrate is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively.
Regorafenib hydrate is a hydrate that is the monohydrate form of anhydrous regorafenib. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It contains a regorafenib.CertificatesBasic Info-
Product Name:
UNII-MGN125FS9D
Other Name:MGN125FS9D
CAS No.:1019206-88-2
Molecular Formula:C21H17ClF4N4O4
InChIKeys:ZOPOQLDXFHBOIH-UHFFFAOYSA-N
Molecular Weight:500.8306928
Exact Mass:500.087433
EC Number:1308068-626-2
UNII:MGN125FS9D
DSSTox ID:DTXSID70144349
Categories:
Characteristics-
PSA:
93.4
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
API,chemical
-
Location:
No. 8 Weiyi Road, Anqing High-tech Industrial Development Zone,Anhui Province,China
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
15
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product